Cost-effectiveness analysis of antiemetic therapy for ambulatory surgery.
Parasuraman
T V
TV
Osterhaus
J T
JT
D000556:Ambulatory Surgical Procedures / Q000191:economics; D000932:Antiemetics / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004329:Droperidol / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D006801:Humans; D008787:Metoclopramide / Q000191:economics / Q000627:therapeutic use; D009325:Nausea / Q000188:drug therapy; D017294:Ondansetron / Q000191:economics / Q000627:therapeutic use; D010359:Patient Readmission / Q000191:economics; D011183:Postoperative Complications / Q000188:drug therapy; D014839:Vomiting / Q000188:drug therapy
D000932:Antiemetics; D017294:Ondansetron; D008787:Metoclopramide; D004329:Droperidol